This trial is conducted in the United states of America (USA). The aim of this trial is to compare two formulations of biphasic insulin aspart 30 in healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
50
Single dose administrated subcutaneously (s.c., under the skin)
Novo Nordisk Investigational Site
San Antonio, Texas, United States
Area under the concentration curve (AUC) of the two formulations from time 0 hours to infinity
Maximum drug concentration of the two formulations (Cmax)
Area under the concentration curve for insulin aspart from time 0 hours to 16 hours
Mean residence time (MRT)
Frequency of adverse events
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.